BLM and prostate cancer: We further divided these patients into high (score ≥ 8) and low BLM expression groups (score < 8) and analyzed the correlation between BLM expression and several common clinicopathological features of prostate cancer (including age, clinical stage, Gleason score, Gleason grade, N-regional lymph nodes, and M-distant metastasis).